Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Samen filgrastim and Neupogen in breast cancer patients
IRCT201206279801N3Phase 3Completed
- Sponsor
- Samen Pharmaceutical
- Start
- Dec 2013
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of filgrastim in breast cancer (2 arms), sponsored by Samen Pharmaceutical. Started Dec 2013; status: completed.
02
Drugs
filgrastim
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT201206279801N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201206279801N3.